相关实验视频
Updated: Jun 26, 2025

05:39
Spontaneous Murine Model of Anaplastic Thyroid Cancer
Published on: February 3, 2023
1.6K
卵泡衍生的甲状腺癌中不常见的分子变化:一个单一机构的研究研究
Borislav A Alexiev1, Erica R Vormittag-Nocito1, Jochen Lorch2
1Department of Pathology, Northwestern University Feinberg School of Medicine, Northwestern Memorial Hospital, 251 East Huron St, Feinberg 7-342A, Chicago, IL 60611, USA.
Pathology, research and practice
|May 19, 2024
概括
不常见的遗传变化导致侵袭性甲状腺癌,包括乳头和差异化类型. 分子测试对于识别高度甲状腺癌中可操作的突变和融合至关重要,从而改善患者管理.
科学领域:
- 内分泌学 在内分泌学.
- 在瘤学瘤学.
- 分子生物学分子生物学
背景情况:
- 甲状腺癌是常见的内分泌恶性瘤,通常与MAPK和PI3K/AKT通路变化有关,在分化良好的瘤中.
- 不太常见的分子变化越来越多地被识别在差异化或形甲状腺癌中,通常与攻击性行为有关.
研究的目的:
- 在各种甲状腺癌亚型中识别和表征不常见的遗传变化.
- 研究这些罕见突变和融合的临床意义和潜在治疗点.
- 评估分子测试在高度卵泡衍生的甲状腺癌中的实用性.
主要方法:
- 甲状腺癌患者样本的综合分子分析.
- 鉴定包括基因融合 (例如NSD3::NUTM1,RET::SPECC1L,G3BP2::FGFR2,NTRK1::TPM3) 和突变 (例如MLH1,MSH2) 在内的遗传改变.
- 分子发现与瘤组织学,等级和临床行为的相关性.
主要成果:
- 在乳头状,差分化和高分化甲状腺癌中发现了不常见的遗传变化.
- 几种已识别的变异,如MLH1,MSH2和各种融合,与瘤的攻击性行为有关.
- 一名患有Li Fraumeni综合征的患者表现出NTRK1::TPM3融合,突出显示了驱动突变和癌症倾向综合征之间的联系.
- 队列中100%的高度卵泡衍生的甲状腺癌存在突变或融合,具有预后,生殖系或可采取行动的含义.
结论:
- 非典型的驱动突变和融合存在于侵袭性甲状腺癌中,包括罕见的亚型.
- 对可采取行动的改变进行分子测试对于管理高度甲状腺癌至关重要.
- 在高度毛囊衍生的甲状腺癌中进行常规分子分析,可以产生重要的临床见解并指导治疗决策.
相关概念视频
Cancers Originate from Somatic Mutations in a Single Cell
11.9K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
11.9K
Cancer-Critical Genes II: Tumor Suppressor Genes
7.4K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.4K
Loss of Tumor Suppressor Gene Functions
4.8K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
4.8K
Synthesis and Regulation of Thyroid Hormones
4.5K
Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
4.5K
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K

